Variable phenotypic presentations of renal involvement in Fabry disease: a case series
Related Experiment Video
Updated: Feb 10, 2026

In Vitro Enzyme Measurement to Test Pharmacological Chaperone Responsiveness in Fabry and Pompe Disease
Published on: December 20, 2017
Sarah McCloskey1, Paul Brennan2, John A Sayer1,3
1Renal Services, Newcastle Upon Tyne Hospitals NHS Trust, Newcastle upon Tyne, Tyne and Wear , NE7 7DN, UK.
Abstract:
Fabry disease is an X-linked genetic deficiency in the alpha-galactosidase enzyme resulting in intracellular accumulation of glycosphingolipids and multisystem organ dysfunction. Typically 50% of males and 20% of affected females have renal involvement, ranging from proteinuria or reduced renal function, renal parapelvic cysts and progressive renal disease ultimately requiring transplantation or dialysis. The phenotypic presentation of Fabry disease is incredibly varied and will even vary between family members with the same confirmed genetic mutation. In a cohort of patients affected by Fabry disease in the North East of England we examine the different phenotypic presentations of eight index cases (6 male, 2 female) with predominantly renal disease and the renal manifestations within their family members. The mean age of presentation was 40 years of age (range 23-59 years). Various multisystem manifestations were observed including cardiac, neurological, cerebrovascular and skin involvement. Two of the male index patients reached end stage renal disease (ESRD) requiring renal replacement therapy. Two female index patients had phenotypes limited to hypertension and proteinuria at presentation and the remaining patients had either stable or progressive chronic kidney disease at the time of diagnosis. We demonstrate the need for a high index of suspicion in order to consider Fabry disease as a diagnosis and the importance of cascade genetic screening to identify affected family members so that treatment can be initiated in a timely fashion.
Insights
Fabry disease, a genetic disorder causing glycosphingolipid buildup, presents varied renal symptoms. Early diagnosis through genetic screening is crucial for timely treatment and managing kidney complications.
Area of Science:
- Genetics
- Nephrology
- Rare Diseases
Background:
- Fabry disease is an X-linked genetic disorder caused by alpha-galactosidase deficiency.
- This deficiency leads to glycosphingolipid accumulation and multisystem organ dysfunction.
- Renal involvement is common, affecting males and females, and can progress to end-stage renal disease.
Purpose of the Study:
- To examine phenotypic variability in Fabry disease, focusing on renal manifestations.
- To investigate renal disease presentation in index cases and their family members in North East England.
- To highlight the importance of early diagnosis and cascade genetic screening.
Main Methods:
- Retrospective analysis of eight index cases (6 male, 2 female) with Fabry disease.
- Evaluation of phenotypic presentations and renal manifestations.
- Review of family members' renal involvement.
Main Results:
- Mean age of presentation was 40 years (range 23-59).
- Observed multisystem involvement including cardiac, neurological, cerebrovascular, and skin.
- Two males reached end-stage renal disease; females presented with hypertension and proteinuria or chronic kidney disease.
Conclusions:
- Fabry disease exhibits significant phenotypic variability, even within families.
- A high index of suspicion is necessary for diagnosis.
- Cascade genetic screening is vital for early identification and treatment initiation.
Related Concept Videos
Self-Presentation
Self-Presentation: Self-Monitoring and Self-Handicapping
Strategies of Self-Presentation I: Strategic Self-Presentation
Processes of Self-Presentation
Strategies of Self-Presentation II: Self-Verification
Variability: Analysis
The range is a simple measure of variability, indicating the difference between the highest and...

